Annals of Clinical Psychiatry

, Volume 9, Issue 1, pp 31–51 | Cite as

The Phenomenology of Psychosis Associated with Complex Partial Seizure Disorder

  • Timothy D. Brewerton


Psychosis commonly occurs as a direct result of complex partial seizure disorder (CPSD). This organic mental disorder is indeed “complex” and is easily and frequently misdiagnosed as a variety of functional disorders, including schizophrenia, schizoaffective disorder, bipolar illness, psychotic depression, and, at best, “atypical psychosis.” However, this important clinical syndrome has several clinical features that suggest its presence and which often permit it to be distinguished from other forms of psychosis. Furthermore, this disorder can be successfully treated with limbic anticonvulsants, with or without neuroleptics and/or lithium, but it is generally refractory to neuroleptic medications alone. In this paper, the author reviews the available literature relevant to the clinical phenomenology and treatment of this topic and illustrates the clinical profiles of 10 treatment-refractory patients admitted to a state hospital with previously undiagnosed psychoses secondary to CPSD. This illness needs to be seriously considered in the differential diagnosis of severely ill patients with atypical psychoses refractory to traditional treatments.

Epilepsy complex partial seizures psychosis anticonvulsants mental disorders 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Post RM, Uhde TW, Putnam FW, et al.: Kindling and carbamazepine in affective illness. J Nerv Ment Dis 1982; 170:717–731Google Scholar
  2. 2.
    Heath RG: Schizophrenia: Biochemical and physiologic aberrations. Int J Neuropsych 1966; 2:597–610Google Scholar
  3. 3.
    Heath RG: Brain function and behavior: I. Emotion and sensory phenomena in psychotic patients and in experimental animals. J. Nerv Ment Dis 1975; 160:159–175Google Scholar
  4. 4.
    Ervin F, Epstein AW, King HE: Behavior of epileptic and nonepileptic patients with “temporal spikes.” Arch Neurol Psychiatry 1955; 74:488–497Google Scholar
  5. 5.
    Geschwind N: Behavioral change in temporal lobe epilepsy. Arch Neurol 1977; 34:453Google Scholar
  6. 6.
    Geschwind N, Shader RI, Bear D, et al.: Case 2: Behavioral changes with temporal lobe epilepsy: Assessment and treatment. J Clin Psychiatry 1980; 41(3):89–95Google Scholar
  7. 7.
    Geshwind N: Pathogenesis of behaviour changes in temporal lobe epilepsy. In: Ward A, Penry J, Purpura D, eds. Epilepsy. New York: Raven Press; 1983Google Scholar
  8. 8.
    Stevens J, Livermore A: Kindling of the mesolimbic dopamine system: Animal model of psychosis. Neurology 1978; 28:36–46Google Scholar
  9. 9.
    Stevens JR: Psychiatric implications of psychomotor epilepsy. Arch Gen Psychiatry 1966; 14:461–471Google Scholar
  10. 10.
    Mulder DW, Daly D: Psychiatric symptoms associated with lesions of temporal lobe. JAMA 1952; 150:173–176Google Scholar
  11. 11.
    Rodin EA: Psychiatric disorders associated with epilepsy. Psych Clin North Am 1978; 1:101–115Google Scholar
  12. 12.
    Neppe VM, Tucker GJ: Modern perspectives on epilepsy in relation to psychiatry: Classification and evaluation. Hosp Comm Psychiatry 1988; 39:263–271Google Scholar
  13. 13.
    Sengoku A, Inoue Y, Seino M: Episodic psychotic states in temporal lobe epilepsy: An investigation on their physiopathogenesis. Folia Psychiat Neurol Jpn 1985; 39:279–286Google Scholar
  14. 14.
    Heath RG: Subcortical brain function correlates of psychopathology and epilepsy. In: Shagass C, Gershon S, Friedhoff AJ, eds. Psychopathology and Brain Dysfunction. New York: Raven Press; 1977Google Scholar
  15. 15.
    Gibbs EL, Gibbs FA, Fuster B: Psychomotor epilepsy. Arch Neurol Psychiatry 1948; 60:331–339Google Scholar
  16. 16.
    MacLean P: The limbic system with respect to self-preservation and the preservation of the species. J Nerv Ment Dis 1958; 127:1–11Google Scholar
  17. 17.
    Gloor P: Temporal lobe epilepsy: Its possible contribution to the understanding of the functional significance of the amygdala and of its interaction with neocortical-temporal mechanisms. In: Eleftheriou, ed. The Neurology of the Amygdala. New York: Plenum; 1972: 423–457Google Scholar
  18. 18.
    Hill D: EEG in episodic psychotic and psychopathic behaviour: A classification of data. EEG Clin Neurophysiol 1952; 4:419–442Google Scholar
  19. 19.
    Rodin EA, DeJong RN, Waggoner RW, Bagchi BK: Relationship between certain forms of psychomotor epilepsy and “schizophrenia.” Arch Neurol Psychiatry 1957; 77:449–463Google Scholar
  20. 20.
    Dongier S: Statistical study of clinical and electroencephalographic manifestations of 536 psychotic episodes occurring in 516 epileptics between clinical seizures. Epilepsia 1959/1960; 1:117–132Google Scholar
  21. 21.
    Slater E, Beard AW: The schizophrenia-like psychoses of epilepsy. Br J Psychiatry 1963; 109:95–150Google Scholar
  22. 22.
    Glaser GH: The problem of psychosis in psychomotor temporal lobe epileptics. Epilepsia 1964; 5:271–278Google Scholar
  23. 23.
    Flor-Henry P: Schizophrenic-like reactions and affective psychoses associated with temporal lobe epilepsy: Etiological factors. Am J Psychiatry 1969; 125:400–407Google Scholar
  24. 24.
    Flor-Henry P: Psychosis and temporal lobe epilepsy: A controlled investigation. Epilepsia 1969; 10:363–395Google Scholar
  25. 25.
    Flor-Henry P: Ictal and interictal psychiatric manifestations in epilepsy: Specific or nonspecific? Epilepsia 1972; 13:773–783Google Scholar
  26. 26.
    Sindrup E: EEG findings in patients with psychomotor epilepsy and psychosis. EEG Clin Neurophysiol 1971; 30:255–274Google Scholar
  27. 27.
    Taylor DC: Factors influencing the occurrence of schizophrenia-like psychosis in patients with temporal lobe epilepsy. Psych Med 1975; 5:249–254Google Scholar
  28. 28.
    Kristensen O, Sindrup EH: Psychomotor epilepsy and psychosis. Acta Neurol Scand 1978; 57:361–379Google Scholar
  29. 29.
    Jensen I, Larsen JK: Mental aspects of temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1979; 42:256–265Google Scholar
  30. 30.
    Perez MM, Trimble MR: Epileptic psychosis—diagnostic comparisons with process schizophrenia. Br J Psychiatry 1980; 137:245–249Google Scholar
  31. 31.
    Sherwin I: Psychosis associated with epilepsy: Significance of the laterality of the epileptogenic lesion. J Neurol Neurosurg Psychiatry 1981; 44:83–88Google Scholar
  32. 32.
    Blumer D, Benson DF: Psychiatric manifestations of epilepsy. In: Benson DF, Blumer D, eds. Psychiatric Aspects of Neurologic Disease, Vol. II. New York: Grune and Stratton; 1982: 25–48Google Scholar
  33. 33.
    Trimble MR: The interictal psychoses of epilepsy In: Benson DF, Blumer D, eds. Psychiatric Aspects of Neurologic Disease, Vol. II. New York: Grune and Stratton; 1982: 75–91Google Scholar
  34. 34.
    Monroe RR: Limbic ictus and atypical psychoses. J Nerv Ment Dis 1982; 170:711–716Google Scholar
  35. 35.
    Wolf P, Trimble MR: Biological antagonism and epileptic psychosis. Br J Psychiatry 1985; 146:272–276Google Scholar
  36. 36.
    Horowitz MJ: States of Mind. Analysis of Change in Psychotherapy. New York: Plenum; 1979Google Scholar
  37. 37.
    Gallhofer B, Trimble MR, Frackowiak R, Gibbs J, Jones T: A study of cerebral blood flow and metabolism in epileptic psychosis using positron emission tomography and oxygen. J Neurol Neurosurg Psychiatry 1985; 48:201–206Google Scholar
  38. 38.
    Lion JR: Diagnostic and therapeutic difficulties in atypical illness. J Nerv Ment Dis 1982; 170:766–768Google Scholar
  39. 39.
    Balis GU: Criterion value of atypical drug responses in the diagnosis of atypical psychiatric disorders. J Nerv Ment Dis 1982; 170:737–743Google Scholar
  40. 40.
    Parnas J, Korsgaard S: Epilepsy and psychosis. Acta Psychiat Scand 1982; 66:89–99Google Scholar
  41. 41.
    Levine DN, Finklestein S: Delayed psychosis after right temporoparietal stroke or trauma: Relation to epilepsy. Neurology 1982; 32:267–273Google Scholar
  42. 42.
    Standage KF: Schizophreniform psychosis among epileptics in a mental hospital. Br J Psychiat 1973; 123:231–232Google Scholar
  43. 43.
    Lewis DO: Delinquency, psychomotor epileptic symptoms, and paranoid ideation: A triad. Am J Psychiatry 1976; 133:1395–1398Google Scholar
  44. 44.
    Tucker GJ, Price TRP, Johnson VB, McAllister T: Phenomenology of temporal lobe dysfunction: A link to atypical psychosis—A series of cases. J Nerv Ment Dis 1986; 174:348–356Google Scholar
  45. 45.
    Pollock DC: Models for understanding the antagonism between seizures and psychosis. Prog Neuro-Psychopharmacol Biol Psychiat 1987; 11:483–504Google Scholar
  46. 46.
    Stoudemire A, Nelson A, Houpt JL: Interictal schizophrenia-like psychoses in temporal-lobe epilepsy. Psychosomatics 1983; 24:331–339Google Scholar
  47. 47.
    Stevens JR: Psychiatric aspects of epilepsy. J Clin Psychiatry 1988; 49(Suppl 4):49–57Google Scholar
  48. 48.
    Ardila A, Montañes, Bernal B, Serpa A, Ruiz A: Partial psychic seizures and brain organization. Int J Neurosci 1986; 30:23–32Google Scholar
  49. 49.
    Neppe VM, Tucker GJ: Modern perspectives on epilepsy in relation to psychiatry: Behavioral disturbances of epilepsy. Hosp Comm Psychiatry 1988; 39:389–396Google Scholar
  50. 50.
    Ferguson SM, Rayport M: Psychosis in epilepsy. In: Blumer D, ed. Psychiatric Aspects of Epilepsy. Washington, DC: APA Press; 1984: 229–265Google Scholar
  51. 51.
    Trimble MR: The psychoses of epilepsy and their treatment. In: Trimble MR, ed. The Psychopharmacology of Epilepsy. London: John Wiley; 1985: 83–94Google Scholar
  52. 52.
    Toone B: Psychoses of epilepsy. In: Reynolds EH, Trimble MR, eds. Epilepsy and Psychiatry. Edinburgh: Churchill Livingstone: 1981:113–137Google Scholar
  53. 53.
    Strub RL, Black FW: Neurobehavioral Disorders: A Clinical Approach. Philadelphia: Davis; 1988:389–421Google Scholar
  54. 54.
    Landolt H: Serial-EEG investigation during psychotic episodes in epileptic patients and during schizophrenic attacks. In: Lorentz de Haas AM, ed. Lectures on Epilepsy. London: Elsievier; 1958:91–133Google Scholar
  55. 55.
    Campbell RJ: Campbell's Psychiatric Dictionary, 5th ed. New York: Oxford University Press; 1981Google Scholar
  56. 56.
    Adams RD, Victor M: Principles of Neurology. New York: McGraw-Hill; 1977Google Scholar
  57. 57.
    Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for classification of epilepsies and epileptic syndromes. Epilepsia 1985; 26:268–278Google Scholar
  58. 58.
    Brain WR: Diseases of the Nervous System, 5th ed. London: Oxford University Press; 1955Google Scholar
  59. 59.
    Alter M, Masland RL, Kurtzke JF: Proposed definitions and classifications of epilepsy for epidemiological purposes. In: Alter M, Hauser WA, eds. The Epidemiology of Epilepsy: A Workshop. National Institute of Neurological Diseases and Stroke Monograph No. 14. U.S. Department of Health, Education and Welfare; 1972Google Scholar
  60. 60.
    Sato S, Rose DF: The electroencephalogram in the evaluation of the patient with epilepsy. Neurol Clin 1986; 4:509–529Google Scholar
  61. 61.
    Klass DW: Electroencephalographic manifestations of complex partial seizures. In: Penry JK, Daly DD, eds. Advances in Neurology, Vol. 11. New York: Raven; 1975Google Scholar
  62. 62.
    Klass DW, Espinosa RE, Fisher-Williams M: Analysis of concurrent electroencephalographic and clinical events occurring sequentially during partial seizures. Electroenceph Clin Neurophysiol 1973; 34:728Google Scholar
  63. 63.
    Spencer SS, Williamson PD, Bridgers SL, Mattson RH, Cicchetti DV, Spencer DD: Reliability and accuracy of localization by scalp ictal EEG. Neurology 1985; 35:1567–1575Google Scholar
  64. 64.
    Sammaritano M, de Lotbinere A, Anderman F, Olivier A, Gloor P, Quesney LF: False lateralization by surface EEG of seizure onset in patients with temporal lobe epilepsy and gross focal cerebral lesions. Ann Neurol 1987; 21:361–369Google Scholar
  65. 65.
    Stevens JR, Bigelow L, Denney D, Lipkini J, Livermore AH Jr, Rausche F, Wyatt RJ: Telemetered EEG-EOG during psychotic behaviors of schizophrenia. Arch Gen Psychiatry 1979; 36:251–269Google Scholar
  66. 66.
    Kadrmas A, Winokur G: Manic depressive illness and EEG abnormalities. J Clin Psychiatry 1979; 40:306–307Google Scholar
  67. 67.
    Perris C: A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. Acta Psychiatr Scand 1966; 42:118–152Google Scholar
  68. 68.
    Hays P: Etiological factors in manic-depressive psychoses. Arch Gen Psychiatry 1976; 33:1187–1188Google Scholar
  69. 69.
    Malaie M, Cruz A, Culebras A: The effect of epileptiform discharges on neurohormonal release in epileptic patients with complex partial seizures. Neurology 1988; 38:759–762Google Scholar
  70. 70.
    Sperling MR, Pritchard PB III, Engel J Jr, Daniel C, Sagel J: Prolactin in partial epilepsy: An indicator of limbic seizures. Ann Neurol 1986; 20:716–722Google Scholar
  71. 71.
    Pritchard PB III, Wannamaker BB, Sagel J, Nair R, DeVillier C: Endocrine function following complex partial seizures. Ann Neurol 1983; 14:27–32Google Scholar
  72. 72.
    Galagher BB, Flanigin HF, King DW, Littleton WH: The effect of electrical stimulation of medial temporal lobe structures in epileptic patients upon ACTH, prolactin and growth hormone. Neurology 1987; 37:299–303Google Scholar
  73. 73.
    Bye AME, Nunn KP, Wilson J: Prolactin and seizure activity. Arch Dis Childhood 1985; 60:848–851Google Scholar
  74. 74.
    Malaie M, Culebras A, Miller M: Nocturnal plasma prolactin and cortisol levels in epileptics with complex partial seizures and primary generalized seizures. Ann Neurol 1987; 44:699–702Google Scholar
  75. 75.
    Sperling MR, Wilson G, Engel J Jr, Babb TL, Phelps M, Bradley W: Magnetic resonance imaging in intractable partial epilepsy: Correlated studies. Ann Neurol 1986; 20:57–62Google Scholar
  76. 76.
    Gozukirmizi E, Meyer JS, Okabe T, Amano T, Mortel K, Karacan I: Cerebral blood flow during paroxysmal EEG activation induced by sleep in patients with complex partial seizures. Sleep 1982; 5:329–342Google Scholar
  77. 77.
    Theodore WH, Dorwart R, Holmes M, Porter RJ, DiChiro G: Neuroimaging in refractory partial seizures: Comparison of PET, CT, and MRI. Neurology 1986; 36:750–759Google Scholar
  78. 78.
    Sakai F, Meyer JS, Naritomi H, Hsu M-C: Regional cerebral blood flow and EEG in patients with epilepsy. Arch Neurol 1978; 35:648–657Google Scholar
  79. 79.
    Post RM, Uhde TW, Joffe RT, Bierer L: Medical mimics of psychiatric disorders. In: Medical Mimics of Psychiatric Disorders. Washington, DC: APA Press; 1986:35–76Google Scholar
  80. 80.
    Post RM: Does limbic system dysfunction play a role in affective illness? In: The Limbic System: Functional Organization and Clinical Disorders. New York: Raven; 1986:229–249Google Scholar
  81. 81.
    Marsden CD, Tarsy D, Baldessarini RJ: Spontaneous and drug-induced movement disorders in psychotic patients. In: Benson DF, Blumer D, eds. Psychiatric Aspects of Neurologic Disease, Vol. I. New York: Grune and Stratton; 1975: 219–266Google Scholar
  82. 82.
    Kotagel P, Luders H, Morris HH, Dinner DS, Wyllie E, Godoy J, Rothner AD: Dystonic posturing in complex partial seizures of temporal lobe onset: A new lateralizing sign. Neurology 1989; 1239:196–201Google Scholar
  83. 83.
    Lennox WG: Epilepsy and Related Disorders, Vol 2. Boston: Little-Brown; 1960Google Scholar
  84. 84.
    Markand ON, Wheeler GL, Pollack SL: Complex partial status epilepticus (psychomotor status). Neurology 1978; 28:189–196Google Scholar
  85. 85.
    Mayeux R, Lueders H: Complex partial status epilepticus: Case report and proposal for diagnostic criteria. Neurology 1978; 28:957–961Google Scholar
  86. 86.
    Engel J, Ludwig BI, Fetell M: Prolonged partial complex status epilepticus: EEG and behavioral observations. Neurology 1978; 28:863–869Google Scholar
  87. 87.
    Shalev RS, Amir N: Complex partial status epilepticus. Arch Neurol 1983; 40:90–92Google Scholar
  88. 88.
    Ballenger CE, King DW, Gallagher BB: Partial complex status epilepticus. Neurology 1983; 33:1545–1552Google Scholar
  89. 89.
    Treiman DM, Delgado-Escueta AV: Complex partial status epilepticus. In: Delgado-Escueta AV, Wasterlain CG, eds. Advances in Neurology, Vol. 34. Status Epilepticus. New York: Raven; 1983: 69–81Google Scholar
  90. 90.
    Porter RJ: Recognizing and classifying epileptic seizures and epileptic syndromes. Neurol Clin 1986; 4:495–508Google Scholar
  91. 91.
    Escueta AVD, Bacsal FE, Treiman DM: Complex partial seizures on closed circuit television and EEG: A study of 691 attacks in 79 patients. Ann Neurol 1982; 11:292–300Google Scholar
  92. 92.
    Theodore WH, Porter RJ, Penry JK: Complex partial seizures: Clinical characteristics and differential diagnosis. Neurology 1983; 33:1115–1121Google Scholar
  93. 93.
    Neppe VM: Symptomatology of temporal lobe epilepsy. SA Med J 1981; 62:902–907Google Scholar
  94. 94.
    Yamamoto N, Wantanabe K, Negoro T, Takaesu E, Aso K, Furune S, Takahashi I: Complex partial seizures in children: Ictal manifestations and their relation to clinical course. Neurology 1987; 37:1379–1382Google Scholar
  95. 95.
    Taylor DC, Lochery M: Temporal lobe epilepsy: Origin and significance of simple and complex auras. J Neurol Neurosurg Psychiatry 1987; 50:673–681Google Scholar
  96. 96.
    Holmes GL: Partial seizures in children. Pediatrics 1986; 77:725–731Google Scholar
  97. 97.
    Holmes GL, McKeever M, Adamson M: Absence seizures in children: Clinical and electroencephalographic features. Ann Neurol 1987; 21:268–273Google Scholar
  98. 98.
    Feindel W, Penfield W: Localization of discharge in temporal lobe automatism. Arch Neurol Psychiatry 1954; 72:605–630Google Scholar
  99. 99.
    Penfield W: The twenty-ninth Maudsley lecture: The role of the temporal cortex in certain psychical phenomena. 1955; J Ment Sci 101:451–465Google Scholar
  100. 100.
    Gloor P, Olivier A, Quesney LF, Andermann F, Horowitz S: Role of the limbic system in experiential phenomena of temporal lobe epilepsy. Ann Neurol 1982; 12:129–144Google Scholar
  101. 101.
    Jose CJ, Peres-Cruet J: Incidence and morbidity of self-induced water intoxication in state mental hospital patients. Am J Psychiatry 1979; 136:221–222Google Scholar
  102. 102.
    Blum A, Tempey FW, Lynch WJ: Somatic findings in patients with psychogenic polydipsia. J Clin Psychiatry 1983; 44:55–56Google Scholar
  103. 103.
    Halgren E, Walter RD, Cherlow DG, Crandall PH: Mental phenomena evoked by electrical stimulation of the human hippocampal formation and amygdala. Brain 1978; 101:83–117Google Scholar
  104. 104.
    Stevens JR, Mark VH, Erwin F, Pacheco P, Suematsu K: Deep temporal stimulation in man: Long latency, long lasting psychological changes. Arch Neurol 1969; 21:157–169Google Scholar
  105. 105.
    Jacobson A, Richardson B: Assault experiences of 100 psychiatric inpatients: Evidence of the need for routine inquiry. Am J Psychiatry 1987; 144:908–913Google Scholar
  106. 106.
    Stewart JT, Bartucci RJ: Post-traumatic stress disorder and complex partial seizures. Am J Psychiatry 1986; 143:113–114Google Scholar
  107. 107.
    Jefferys JGR, Williams SF: Physiological and behavioural consequences of seizures induced in the rat by intrahippocampal tetanus toxin. Brain 1987; 110:517–532Google Scholar
  108. 108.
    Brutus M, Shaikh MB, Edinger H, Siegel A: Effects of experimental temporal lobe seizures upon hypothalamically elicited aggressive behavior in the cat. Brain Res 1986; 366:53–63Google Scholar
  109. 109.
    Griffith, N, Engel J, Bandler R: Ictal and enduring interictal disturbances in emotional behaviour in an animal model of temporal lobe epilepsy. Brain Res 1987; 400:360–364Google Scholar
  110. 110.
    Goddard G: The kindling model of limbic epilepsy. In: Girgis M, Kilho LG, eds. Limbic Epilepsy and the Dyscontrol Syndrome. Amsterdam: Elsevier; 1980Google Scholar
  111. 111.
    Post RM, Rubinow DR, Ballenger JC: Conditioning, sensitization, and kindling: Implications for the course of affective illness. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore: Williams & Williams; 1984:432–465Google Scholar
  112. 112.
    Post RM, Ballenger JC, Uhde TW, Bunney WE: Efficacy of carbamazepine in manic-depressive illness: Implications for underlying mechanisms. In: Post RM, Ballenger JC, eds. Neurobiology of Mood Disorders. Baltimore: Williams & Williams; 1984:777–816Google Scholar
  113. 113.
    Rossi A, Stratta P, Gallucci M, Amicarelli I, Passariello R, Casacchia M: Standardized magnetic resonance image intensity study in schizophrenia. Psychiatry Res 1988; 25:223–231Google Scholar
  114. 114.
    Rossi A, Stratta P, D'Albenzio L, Tartaro A, Schiazza G, Di Michell V, Ceccoli S, Casacchia M: Reduced temporal lobe area in schizophrenia by magnetic resonance imaging: Preliminary evidence. Psychiatry Res 1989; 29:261–263Google Scholar
  115. 115.
    Suddath RL, Casanova MF, Goldberg TE, Daniel DG, Kelsoe JR, Weinberger DR: Temporal lobe pathology in schizophrenia: A quantitative magnetic resonance imaging study. Am J Psychiatry 1989; 146:464–472Google Scholar
  116. 116.
    McCarley RW, Faux SF, Shenton M, LeMay M, Cane M, Ballinger R, Duffy FH: CT abnormalities in schizophrenia. A Preliminary study of their correlations with P300/P200 electrophysiological features and positive/negative symptoms. Arch Gen Psychiatry 1989; 46:698–708Google Scholar
  117. 117.
    Rossi A, Stratta P, D'Albenzio L, Tartaro A, Schiazza G, di Michele V, Bolino F, Casacchia M: Reduced temporal lobe areas in schizophrenia: Preliminary evidences from a controlled multiplanar magnetic resonance imaging study. Biol Psychiatry 1990; 27:61–68Google Scholar
  118. 118.
    Joseph AB, O'Leary DH, Wheeler HG: Bilateral atrophy of the frontal and temporal lobes in schizophrenic patients with Capgras syndrome: A case-control study using computed tomography. J Clin Psychiatry 1990; 51:322–325Google Scholar
  119. 119.
    Bogerts B, Ashtari M, Degreef G, Alvir JMJ, Bilder RM, Lieberman JA: Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Res 1990; 35:1–13Google Scholar
  120. 120.
    Johnstone EC, Cowens DG, Crow TJ, Frith CD, Alexandropolis K, Bydder G, Colter N: Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder. J Neurol Neurosurg Psychiatry 1989; 52:736–741Google Scholar
  121. 121.
    Kovelman JA, Scheibel AB: A neurohistological correlate of schizophrenia. Biol Psychiatry 1984; 19:1601–1621Google Scholar
  122. 122.
    Bogerts B, Meertz E, Schonfeldt-Bausch R: Basal ganglia and limbic system pathology in schizophrenia. A morphometric study of brain volume and shrinkage. Arch Gen Psychiatry 1985; 42:784–791Google Scholar
  123. 123.
    Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, Johnstone EC, Marsh L: Postmortem evidence of structural brain changes in schizophrenia. Arch Gen Psychiatry 1986; 43:36–42Google Scholar
  124. 124.
    Weinberger DR: Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987; 44:660–669Google Scholar
  125. 125.
    Roberts GW, Colter N, Lofthouse R, Johnstone EC, Crow TJ: Is there gliosis in schizophrenia? Investigation of the temporal lobe. Biol Psychiatry 1987; 22:1459–1468Google Scholar
  126. 126.
    Falkai P, Bogerts B, Rozumek M: Limbic pathology in schizophrenia: The entorhinal region—a morphometric study. Biol Psychiatry 1988; 24:515–521Google Scholar
  127. 127.
    Altshuler LL, Casanova MF, Goldberg TE, Kleinman JE: The hippocampus and parahippocampus in schizophrenic, suicide, and control brains. Arch Gen Psychiatry 1990; 47:1029–1034Google Scholar
  128. 128.
    Bruton CJ, Crow TJ, Frith CD, Johnstone EC, Owens DGC, Roberts GW: Schizophrenia and the brain: A prospective clinico-neuropathological study. Psychol Med 1990; 20:285–304Google Scholar
  129. 129.
    Rosenbaum DH, Siegel M, Barr WB, Rowan AJ: Epileptic aphasia. Neurology 1986; 36:822–825Google Scholar
  130. 130.
    Fischer-Williams M, Bickford RG, Whisnant JP: Occipito-parieto-temporal seizure discharge with visual hallucinations and aphasia. Epilepsia 1964; 5:279–292Google Scholar
  131. 131.
    Mayeux R, Brandt J, Rosen J, Benson DF: Interictal memory and language impairment in temporal lobe epilepsy. Neurology 1980; 30:120–125Google Scholar
  132. 132.
    Daly DD: Ictal clinical manifestations of complex partial seizures. In: Penry JK, Daly DD, eds. Advances in Neurology, Vol. II. New York: Raven Press; 1975:57–83Google Scholar
  133. 133.
    Jacome DE, Seroppian ER: Case report: Ictal bradycardia. Am J Med Sci 1988; 295:469–471Google Scholar
  134. 134.
    Singhi PD, Kaur S: Abdominal epilepsy misdiagnosed as psychogenic pain. Postgrad Med J 1988; 64:281–282Google Scholar
  135. 135.
    Semel JD: Complex partial status epilepticus presenting as fever of unknown origin. Arch Intern Med 1987; 147:1571–1572Google Scholar
  136. 136.
    Strauss E, Risser A, Jones MW: Fear responses in patients with epilepsy. Arch Neurol 1982; 39:626–630Google Scholar
  137. 137.
    Mesulam MM: Dissociative states with abnormal temporal lobe EEG: Multiple personality and the illusion of possession. Arch Neurol 1981; 38:176–181Google Scholar
  138. 138.
    Signer SF, Benson DF: The ease with which epileptic seizures avoid diagnosis. Am J Psychiatry 1986; 143:552–553Google Scholar
  139. 139.
    Reid TL, Raj BA, Sheehan DR: Ictal panic/epileptogenic activity: Treatment with primidone. Psychosomatics 1988; 29:431–433Google Scholar
  140. 140.
    Weilburg JB, Bear DM, Sachs G: Three patients with concomitant panic attacks and seizure disorder: Possible clues to the neurology of anxiety. Am J Psychiatry 1987; 144:1053–1056Google Scholar
  141. 141.
    Devinsky O, Sato S, Theodore WH, Porter RJ: Fear episodes due to limbic seizures with normal ictal scalp EEG: A subdural electrographic study. J Clin Psychiatry 1989; 50:28–30Google Scholar
  142. 142.
    Volkow ND, Harper A, Swann AC: Temporal lobe abnormalities and panic attacks. Am J Psychiatry 1986; 143:1484–1485Google Scholar
  143. 143.
    Greenstein RA, Kitchner I, Olsen K: Posttraumatic stress disorder, partial complex seizures, and alcoholism. Am J Psychiatry 1986; 143:1203Google Scholar
  144. 144.
    Signer SF: Seizure disorder or panic disorder? Am J Psychiatry 1988; 145:275–276Google Scholar
  145. 145.
    Van Sweden B, Rombaut P: Panic attacks and EEG abnormalities. Am J Psychiatry 1987; 144:1624Google Scholar
  146. 146.
    Weilburg JB, Pollack M, Murray GB, Barber HJ: On panic attacks and neurologic problems. Am J Psychiatry 1986; 143:1626–1627Google Scholar
  147. 147.
    Naito H, Matsui N: Single case study. Temporal lobe epilepsy with ictal ecstatic state and interictal behavior of hypergraphia. J Nerv Ment Dis 1988; 176:123–124Google Scholar
  148. 148.
    Tucker DM, Novelly RA, Walker PJ: Brief communication: Hyper-religiosity in temporal lobe epilepsy: Redefining the relationship. J Nerv Ment Dis 1987; 175:181–184Google Scholar
  149. 149.
    Schenk L, Bear D: Multiple personality and related dissociative phenomena in patients with temporal lobe epilepsy. Am J Psychiatry 1981; 138:1311–1316Google Scholar
  150. 150.
    Drake ME Jr, Pakalnis A, Denio LC: Differential diagnosis of epilepsy and multiple personality. Neuropsychiatry Neuropsychol Behav Neurol 1988; 1:131–140Google Scholar
  151. 151.
    Damasio AR, Damasio H, Van Hoesen GW: Prosopagnosia: Anatomic basis and behavioral mechanisms. Neurology 1982; 32:331–341Google Scholar
  152. 152.
    Gabr M, Luders H, Dinner D, Morris H, Wyllie E: Speech manifestations in lateralization of temporal lobe seizures. Ann Neurol 1989; 25:82–87Google Scholar
  153. 153.
    Cummings JL: Organic psychosis. Psychosomatics 1988; 29:16–26Google Scholar
  154. 154.
    Berson RJ: Capgras' syndrome. Am J Psychiatry 1983; 140:969–978Google Scholar
  155. 155.
    Cummings JL: Organic psychoses: Delusional disorders and secondary mania. Psych Clin North Am 1986; 9:293–311Google Scholar
  156. 156.
    Jung CG: Four Archetypes. Princeton, NJ: Bollingen; 1959Google Scholar
  157. 157.
    Bear DM: Temporal lobe epilepsy: A syndrome of sensory-limbic hyperconnection. Cortex 1979; 15:357–384Google Scholar
  158. 158.
    Bear DM, Fedio P: Quantitative analysis of interictal behavior in temporal lobe epilepsy. Arch Neurol 1977; 34:454–467Google Scholar
  159. 159.
    Benson DF: Interictal behavior disorders in epilepsy. Psych Clin North Am 1986; 9:283–292Google Scholar
  160. 160.
    Mayeux R, Alexander MP, Benson FD, Brandt J, Rosen J: Poriomania. Neurology 1979; 29:1616–1619Google Scholar
  161. 161.
    Campbell J: Hero with a Thousand Faces. New York: Pantheon Books; 1949Google Scholar
  162. 162.
    Dewhurst K, Beard AW: Sudden religious conversions in temporal lobe epilepsy. Br J Psychiatry 1970; 117:497–507Google Scholar
  163. 163.
    Pahnke WN, Richards WA: Implications of LSD and experimental mysticism. J Religion Health 1966; 5:175Google Scholar
  164. 164.
    Remillard GM, Andermann F, Testa GF, Gloor P, Aube M, Martin JB, Feindel W, Guberman A, Simpson C: Sexual ictal manifestations predominate in women with temporal lobe epilepsy: A finding suggesting sexual dimorphism in the human brain. Neurology 1983; 33:323–330Google Scholar
  165. 165.
    Adey WR, Bell FR, Dennis BJ: Effects of LSD-25, psilocybin, and psilocin on temporal lobe EEG patterns and learned behavior in the cat. Neurology 1962; 12:591–602Google Scholar
  166. 166.
    Blumer D: Hypersexual episodes in temporal lobe epilepsy. Am J Psychiatry 1970; 126:1099–1106Google Scholar
  167. 167.
    Ingvar DH, Söderberg V: The effect of LSD-25 upon the cerebral blood flow and EEG in cats. Experientia 1956; 12:427–429Google Scholar
  168. 168.
    Monroe RR, Heath RG: Effects of lysergic acid and various derivatives on depth and cortical electrograms. J Neuropsychiatry 1961; 3:75–82Google Scholar
  169. 169.
    Adey WR, Porter R, Walter DO, Brown TS: Prolonged effects of LSD on EEG records during discriminative performance in cat; evaluation by computer analysis. EEG Clin Neurophysiol 1965; 18:25–35Google Scholar
  170. 170.
    Richards NG: Lowered seizure threshold after LSD. EEG Clin Neurophysiol 1974; 37:331Google Scholar
  171. 171.
    Kluver H, Bucy PC: “Psychic blindness” and other symptoms following bilateral temporal lobectomy in Rhesus monkeys. Am J Physiol 1937; 119:352–353Google Scholar
  172. 172.
    Kluver H, Bucy PC: Preliminary analysis of functions of the temporal lobes in rhesus monkeys. Arch Neurol Psychiatry 1939; 42:979–1000Google Scholar
  173. 173.
    Brewerton TD: Hyperreligiosity in psychotic disorders. J Nerv Ment Dis 1994; 182:302–304Google Scholar
  174. 174.
    Fenwick PBC: The influence of mind on seizure activity. In: Devinsky O, Theodore WH, eds. Epilepsy and Behavior. New York: Wiley-Liss; 1991:405–419Google Scholar
  175. 175.
    Anderson NE, Wallis WE: Activation of epileptiform activity by mental arithmetic. Arch Neurol 1986; 43:624–626Google Scholar
  176. 176.
    Pritchard PB III, Holmstrom VL, Giacinto J: Self-abatement of complex partial seizures. Ann Neurol 1985; 18:265–267Google Scholar
  177. 177.
    Sillanpaa M: Carbamazepine: Pharmacology and clinical uses. Acta Neurol Scand 1981; 64(Suppl 88):1–202Google Scholar
  178. 178.
    Dalby DD: Behavioral effects of carbamazepine. In: Penry JK, Daly DD, eds. Advances in Neurology, Vol. II. New York: Raven Press; 1975: 331–344Google Scholar
  179. 179.
    Ayd F: Carbamazepine's acute and prophylactic effects in manic and depressive illness: An update. Int Drug Ther Newslett 1982; 17(2,3):5–10Google Scholar
  180. 180.
    Ayd F (ed): Carbamazepine for aggression, schizophrenia and nonaffective syndrome. Int Drug Ther Newslett 1984; 19(3):9–12Google Scholar
  181. 181.
    Ballenger JC, Post RM: Carbamazepine in manic-depressive illness: A new treatment. Am J Psychiatry 1980; 137:792–790Google Scholar
  182. 182.
    Post RM: Use of the anticonvulsant carbamazepine in primary and secondary affective illness: Clinical and theoretical implications. Psychol Med 1982; 12:701–704Google Scholar
  183. 183.
    Okuma T: Therapeutic and prophylactic effects of carbamazepine in bipolar disorders. Psychiatr Clin North Am 1983; 6:157–173Google Scholar
  184. 184.
    Folks DG, King LD, Dowdy SB, Petrie WM, Jack RA, Koomer JC, Swenson BR, Edwards P: Carbamazepine treatment of selected affectively disordered inpatients. Am J Psychiatry 1982; 139:115–117Google Scholar
  185. 185.
    Post RM, Uhde TW, Ballenger JC, Squillace KM: Prophylactic efficacy of carbamazepine in manic-depressive illness. Am J Psychiatry 1983; 140:1602–1604Google Scholar
  186. 186.
    Tunks ER, Dermer SW: Carbamazepine in the dyscontrol syndrome associated with limbic system dysfunction. J Nerv Ment Dis 1977; 164:56–63Google Scholar
  187. 187.
    Neppe VM: Carbamazepine in the psychiatric patient. Lancet 1982; 2:334Google Scholar
  188. 188.
    Neppe VM: Carbamazepine as adjunctive treatment in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. J Clin Psychiatry 1983; 44:326–331Google Scholar
  189. 189.
    Hakola HPA, Laulumaa VA: Carbamazepine in treatment of violent schizophrenics. Lancet 1982; 1:135Google Scholar
  190. 190.
    Klein E, Bental E, Lerer B, Belmaker RH: Carbamazepine and haloperidol v. placebo and haloperidol in excited psychoses: A controlled study. Arch Gen Psychiatry 1984; 41:165–170Google Scholar
  191. 191.
    Brewerton TD: Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect. Biol Psychiatry 1986; 21:677–685Google Scholar
  192. 192.
    Brewerton TD, Kramlinger KG, Post RM: Combination therapy with lithium and carbamazepine. In: Birch NJ, ed. Lithium: Inorganic Pharmacology and Psychiatric Use. Oxford: IRL Press; 1988:57–60Google Scholar
  193. 193.
    Lipinski JF, Pope HG: Possible synergistic action between carbamazepine and lithium carbonate in the treatment of three acutely manic patients. Am J Psychiatry 1982; 139:948–949Google Scholar
  194. 194.
    Nolen WA: Carbamazepine, a possible adjunct or alternative to lithium in bipolar disorder. Acta Psychiatr Scand 1983; 67:218–225Google Scholar
  195. 195.
    Moss GR, James CR: Carbamazepine synergism in mania. Arch Gen Psychiatry 1983; 40:588–589Google Scholar
  196. 196.
    Keisling R: Carbamazepine and lithium carbonate in the treatment of refractory affective disorders. Arch Gen Psychiatry 1983; 40:223Google Scholar
  197. 197.
    Post RM, Uhde TW: Carbamazepine and lithium carbonate synergism in mania. Arch Gen Psychiatry 1984; 41:210Google Scholar
  198. 198.
    Chaudhry RP, Waters BGH: Lithium and carbamazepine interaction: Possible neurotoxicity. J Clin Psychiatry 1983; 44:30–31Google Scholar
  199. 199.
    Strange J, Shah A: An open clinical trial of carbamazepine in treatment-resistent bipolar and schizo-affective psychotics. Br J Psychiatry 1985; 147:198–200Google Scholar
  200. 200.
    Cegalis JA, Possick SG: Carbamazepine and psychotherapy in the treatment of schizoaffective psychosis. Yale J Biol Med 1985; 58:327–336Google Scholar
  201. 201.
    Kramlinger KG, Post RM: Adding lithium carbonate to carbamazepine: Antimanic efficacy in treatment-resistant mania. Acta Psychiatr Scand 1989; 79:378–385Google Scholar
  202. 202.
    Neppe VM: Carbamazepine in nonresponsive patients. J Clin Psychiatry 1988; 49(Suppl 4):22–28Google Scholar
  203. 203.
    Azorin JM, Samuelian JC, Pringuey D, Donnet A, Tottai Th, Dufour H, Tatossian A: Place de la carbamazépine dans le traitement des psychoses endogènes. Encephale 1986; 12:115–119Google Scholar
  204. 204.
    Dose M, Apelt S, Emrich HM: Carbamazepine as an adjunct of antipsychotic therapy. Psychiatry Res 1987; 22:303–310Google Scholar
  205. 205.
    De Vogelaer J: Carbamazepine in the treatment of psychotic and behavioral disorders: A pilot study. Acta Psychiat Belg 1981; 81:532–541Google Scholar
  206. 206.
    Gardner DL, Cowdry RW: Positive effects of carbamazepine on behavioral dyscontrol in borderline personality disorder. Am J Psychiatry 1986; 143:519–522Google Scholar
  207. 207.
    Post RM, Uhde TW, Roy-Byrne PP, Joffe RT: Antidepressant effects of carbamazepine. Am J Psychiatry 1986; 143:29–34Google Scholar
  208. 208.
    Stewart JT: Carbamazepine treatment of a patient with Klüver-Bucy syndrome. J Clin Psychiatry 1985; 46:496–497Google Scholar
  209. 209.
    Stramek J, Herrera J, Costa J, Heh C, Tran-Johnson T, Simpson G: A carbamazepine trial in chronic, treatment-refractory schizophrenia. Am J Psychiatry 1988; 145:748–750Google Scholar
  210. 210.
    Stone JL, McDaniel KD, Hughes JR, Hermann BP: Episodic dyscontrol disorder and paroxysmal EEG abnormalities: Successful treatment with carbamazepine. Biol Psychiatry 1986; 21:208–212Google Scholar
  211. 211.
    Ballenger JC, Post RM: Carbamazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull 1984; 20:572–584Google Scholar
  212. 212.
    Post RM, Leverich GS, Rosaff AS, Altshuler LL: Carbamazepine prophylaxis in refractory affective disorders: A focus on long-term follow-up. J Clin Psychopharmacol 1990; 10:318–327Google Scholar
  213. 213.
    Post RM: Non-lithium treatment for bipolar disorder. J Clin Psychiatry 1990; 51(Suppl 8):9–16Google Scholar
  214. 214.
    Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K: Comparison of the antimanic efficacy of carbamazepine and lithium carbonate by double-blind controlled study. Pharmacopsychiatry 1990; 23:143–150Google Scholar
  215. 215.
    Mauri MC, Percudani M, Regazzetti MG, Altamura AC: Alternative prophylactic treatments to lithium in bipolar disorders. Clin Neuropharmacol 1990; 13(Suppl 1):S90–S96Google Scholar
  216. 216.
    Stuppaeck C, Barnas C, Miller C, Schwitzer J, Fleischhacker WW: Carbamazepine in the prophylaxis of mood disorders. J Clin Psychopharmacol 1990; 10:39–42Google Scholar
  217. 217.
    Placidi GF, Lenzi A, Lazzerini F, Cassano GB, Akiskal HS: The comparative efficacy and safety of carbamazepine versus lithium: A randomized, double-blind 3-year trial in 83 patients. J Clin Psychiatry 1986; 47:490–494Google Scholar
  218. 218.
    Guay DRP: The emerging role of valproate in bipolar disorder and other psychiatric disorders. Pharmacotherapy 1995; 15:631–647Google Scholar
  219. 219.
    Raju SS: Case report: carbamazepine therapy in schizophrenia. Indian J Psychiatry 1984; 26:242–244Google Scholar
  220. 220.
    McAllister TW: Carbamazepine in mixed frontal lobe and psychiatric disorders. J Clin Psychiatry 1985; 46:393–394Google Scholar
  221. 221.
    Okuma T, Yamashita I, Takahashi R, Itoh H, Otsuki S, Watanabe S, Sarai K, Hazama H, Inanaga K: A double-blind study of adjunctive carbamazepine versus placebo on excited states of schizophrenic and schizoaffective disorders. Acta Psychiatr Scand 1989; 80:250–259Google Scholar
  222. 222.
    Heh CWC, Potkin SG, Pickar D, Costa J, Herrera J, Sramek J, DeMet E: Serum homovanillic acid concentrations in carbamazepine-treated chronic schizophrenics. Biol Psychiatry 1989; 25:639–641Google Scholar
  223. 223.
    Carpenter WT, Kurz R, Kirkpatrick B, Hanion TE, Summerfelt AT, Buchanan RW, Waltrip RW, Breier A: Carbamazepine maintenance treatment in outpatient schizophrenics. Arch Gen Psychiatry 1991; 48:69–72Google Scholar
  224. 224.
    Garbutt JC, Loosen PT: Is carbamazepine helpful in paroxysmal behavior disorders? Am J Psychiatry 1983; 140:1363–1364Google Scholar
  225. 225.
    Lenzi A, Lazzerini F, Grossi E, Massimetti G, Placidi GF: Use of carbamazepine in acute psychosis: A controlled study. J Intern Med Res 1986; 14:78–84Google Scholar
  226. 226.
    Elphick M: An open clinical trial of carbamazepine in treatment-resistant bipolar and schizoaffective psychotics. Br J Psychiatry 1985; 147:198–200Google Scholar
  227. 227.
    MacCrimmon DJ, Jones GB: Limbic system dysfunction as a factor in some schizophreniform psychoses: Case report and overview. Can J Psychiatry 1986; 31:344–346Google Scholar
  228. 228.
    Herrera JM, Sramek JJ, Costa JF: Efficacy of adjunctive carbamazepine in the treatment of chronic schizophrenia. Drug Intell Clin Pharm 1987; 21:355–358Google Scholar
  229. 229.
    Rankel HW, Rankel LE: Carbamazepine in the treatment of catatonia. Am J Psychiatry 1988; 145:361–362Google Scholar
  230. 230.
    Schaffer CB, Mungas D, Rockwell E: Successful treatment of psychotic depression with carbamazepine. J Clin Psychopharmacol 1985; 5:233–235Google Scholar
  231. 231.
    Peet M, Collier J: Use of carbamazepine in psychosis after neuroleptic malignant syndrome. Br J Psychiatry 1990; 156:579–581Google Scholar
  232. 232.
    Sultan S, Chouinard G, Beaudry P: Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis. Progr Neuro-Psychopharm Biol Psychiatry 1990; 14:431–438Google Scholar
  233. 233.
    Anton RF, Waid LR, Fossey M, AuBuchon P: Case report of carbamazepine treatment of organic brain syndrome with psychotic features. J Clin Psychopharmacol 1986; 6:232–234Google Scholar
  234. 234.
    Vallini AD, Burns RL: Carbamazepine as therapy for psychiatric sequelae of herpes simplex encephalitis. Southern Med J 1987; 80:1590–1592Google Scholar
  235. 235.
    Scher M, Neppe V: Carbamazepine adjunct for nonresponsive psychosis with prior hallucinogenic abuse. J Nerv Ment Dis 1989; 177:755–757Google Scholar
  236. 236.
    Trimble MR: The Psychoses of Epilepsy. New York: Raven Press; 1991Google Scholar
  237. 237.
    Garbutt JC, Gillette GM: Apparent complex partial seizures in a bipolar patient after withdrawal of carbamazepine. J Clin Psychiatry 1988; 49:410–411Google Scholar
  238. 238.
    Heh CWC, Sramek J, Herrera J, Costa J: Exacerbation of psychosis after discontinuation of carbamazepine treatment. Am J Psychiatry 1988; 145:878–879Google Scholar
  239. 239.
    Stevens JR: Interictal clinical manifestations of complex partial seizures. In: Penry, JK, Daly DD (eds.), Advances in Neurology: Complex Partial Seizures and Their Treatment, Vol. II. New York: Raven Press; 1975Google Scholar
  240. 240.
    Drake ME, Peruzzi WT: Manic state with carbamazepine therapy of seizures. J Natl Med Assoc 1986; 78:1105–1107Google Scholar
  241. 241.
    Pakalnis A, Drake ME, John K, Kellem JB: Forced normalization. Acute psychosis after seizure control in seven patients. Arch Neurol 1987; 44:289–292Google Scholar
  242. 242.
    Kidron R, Averbuch I, Klein E, Belmaker RH: Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia. Biol Psychiatry 1985; 20:199–228Google Scholar
  243. 243.
    Arana GW, Goff DC, Friedman H, Ornsteen M, Greenblatt DJ, Black B, Shader RI: Does carbamazepine-induced reduction of plasma haloperidol levels worsen psychotic symptoms? Am J Psychiatry 1986; 143:650–651Google Scholar
  244. 244.
    Coryell W, Kelly M, Perry PJ, Miller DD: Haloperidol plasma levels and acute clinical change in schizophrenia. J Clin Psychopharmacol 1990; 10:397–402Google Scholar
  245. 245.
    Kahn EM, Schulz SC, Perel JM, Alexander JE: Change in haloperidol level due to carbamazepine—A complicating factor in combined medication for schizophrenia. J Clin Psychopharmacol 1990; 10:54–57Google Scholar
  246. 246.
    Csernansky JG, Holman CA, Hollister LE: Variability and the dopamine hypothesis of schizophrenia. Schizo Bull 1983; 9:325–328Google Scholar
  247. 247.
    Jus A, Villeneuve A, Gautier J, Pires A, Cote JM, Jus K, Villeneuve R, Perron D: Some remarks on the influence of lithium carbonate on patients with temporal lobe epilepsy. Int J Clin Pharmacol Biopharm 1973; 7:67–74Google Scholar
  248. 248.
    Erwin CW, Gerber CJ, Morrison SD, James JF: Lithium carbonate and convulsive disorders. Arch Gen Psychiatry 1973; 28:646–648Google Scholar
  249. 249.
    Tucker GJ, Price TRP, Johnson VB, McAllister T: Phenomenology of temporal lobe dysfunction: A link to atypical psychosis—A series of cases. J Nerv Ment Dis 1986; 174:348–356Google Scholar
  250. 250.
    Bear DM, Levin K, Blumer D: Interictal behaviour in hospitalized temporal lobe epileptics: Relationship to idiopathic psychiatric syndromes. J Neurol Neurosurg Psychiatry 1982; 45:481–488Google Scholar
  251. 251.
    Waxman SG, Geschwind N: Hypergraphia in temporal lobe epilepsy. Neurology 1974; 24:629–636Google Scholar
  252. 252.
    Sachdev HS, Waxman SG: Short report: Frequency of hypergraphia in temporal lobe epilepsy: An index of interictal behaviour syndrome. J Neurol Neurosurg Psychiatry 1981; 44:358–360Google Scholar
  253. 253.
    Hermann BP, Whitman S, Arntson P: Hypergraphia in epilepsy: Is there a specificity to temporal lobe epilepsy? J Neurol Neurosurg Psychiatry 1983; 46:848–853Google Scholar
  254. 254.
    Blumer D, Walker AE: Sexual behavior in temporal lobe epilepsy. Arch Neurol 1967; 16:37–43Google Scholar
  255. 255.
    Drake ME Jr, Coffey CE: Complex partial status epilepticus simulating psychogenic unresponsiveness. Am J Psychiatry 1983; 140:6:800–801Google Scholar
  256. 256.
    Brandt J, Seidman LJ, Kohl D: Personality characteristics of epileptic patients: A controlled study of generalized and temporal lobe cases. J Clin Exp Neuropsychol 1985; 7:25–38Google Scholar
  257. 257.
    Rocca WA, Sharbrough FW, Hauser WA, Annegers JF, Schoenberg BS: Risk factors for complex partial seizures: A population-based case-control study. Ann Neurol 1987; 21:22–31Google Scholar
  258. 258.
    Herzberg, JL, Fenwick, PBC: The aetiology of aggression in temporal-lobe epilepsy. Br J Psychiatry 1988; 153:50–55Google Scholar
  259. 259.
    Landsborough D: St. Paul and temporal lobe epilepsy. J Neurol Neurosurg Psychiatry 1987; 50:659–664Google Scholar
  260. 260.
    Tucker GJ, Novelly RA, Walker PJ: Brief Communication. Hyper-religiosity in temporal lobe epilepsy: Redefining the relationship. J Nerv Ment Dis 1987; 175:181–184Google Scholar
  261. 261.
    Hermann BP, Dikmen S, Schwartz MS, Karnes WE: Interictal psychopathology in patients with ictal fear: A quantitative investigation. Neurology 1982; 32:7–11Google Scholar
  262. 262.
    Fedio P: Behavioral characteristics of patients with temporal lobe epilepsy. Psych Clin North Am 1986; 9:267–281Google Scholar
  263. 263.
    Schwarz BE, Bickford RG, Mulder DW, Rome HP: Mescaline and LSD-25 in activation of temporal lobe epilepsy. Neurology 1956; 6:275–280Google Scholar
  264. 264.
    Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z: A specific laboratory test for the diagnosis of melancholia. Arch Gen Psychiatry 1981; 38:15–22Google Scholar
  265. 265.
    Stoll AL, Banov M, Kolbrener M, Mayer PV, Tohen M, Strakowski SM, Castillo J, Suppes T, Cohen BM: Neurologic factors predict a favorable valproate response in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994; 14:311–313Google Scholar
  266. 266.
    Mazure CM, Druss BJ, Cellar JS: Valproate treatment of older psychotic patients with organic mental syndromes and behavioral dyscontrol. J Am Geriatr Soc 1992; 40:914–916Google Scholar
  267. 267.
    Nasser D, Thomas B: Anticonvulsant treatment of psychoses. Austr NZ J Psychiatry 1990; 24:164Google Scholar
  268. 268.
    Wassef A, Watson DJ, Morrison P, Bryant S, Flach J: Neuroleptic-valproate acid combination in treatment of psychotic symptoms: A three-case report. J Clin Psychopharmacol 1989; 9:45–48Google Scholar
  269. 269.
    Hayes SG: Long-term use of valproate in primary psychiatric disorders. J Clin Psychiatry 1989; 50(Suppl):35–39Google Scholar
  270. 270.
    Scaff MR, Fawcett J, Zajecka JM: Divalproex sodium in the treatment of refractory affective disorders. J Clin Psychiatry 1993; 54:380–384Google Scholar
  271. 271.
    VanValkenburg C, Kluznik J, Merrill R, Erickson W: Therapeutic levels of valproate for psychosis. Psychopharmacol Bull 1990; 26:254–255Google Scholar
  272. 272.
    Kando JC, Tohen M, Castillo J, Centorrino F: Concurrent use of clozapine and valproate in affective and psychotic disorders. J Clin Psychiatry 1994; 55:255–257Google Scholar
  273. 273.
    Tohen M, Castillo J, Pope HG, Herbstein J: Concomitant use of valproate and carbamazepine in bipolar and schizoaffective disorders. J Clin Psychopharmacol 1994; 14:67–70Google Scholar
  274. 274.
    Cavanaugh S, Glicenstein C: Intravenous lorazepam in the treatment of postictal psychosis. Psychosomatics 1993; 34:443–445Google Scholar
  275. 275.
    Walton NY, Treiman DM: Lorazepam treatment of experimental status epilepticus in the rat: Relevance to clinical practice. Neurology 1990; 40:990–994Google Scholar
  276. 276.
    Lacey DJ, Singer WD, Horwitz SJ, Gilmore HG: Lorazepam therapy of status epilepticus in children and adolescents. J Pediatr 1986; 108:771–774Google Scholar
  277. 277.
    Moffett A, Scott DF: Stress and epilepsy: The value of a benzodiazepine—lorazepam. J Neurol Neurosurg Psychiatry 1984; 47:165–167Google Scholar
  278. 278.
    Keats MM, Mukherjee S: Antiaggressive effect of adjunctive clonazepam in schizophrenia associated with seizure disorder. J Clin Psychiatry 1988; 49:117–118Google Scholar

Copyright information

© American Academy of Clinical Psychiatrists 1997

Authors and Affiliations

  • Timothy D. Brewerton
    • 1
  1. 1.Institute of Psychiatry, Department of Psychiatry and Behavioral SciencesMedical University of South CarolinaCharleston

Personalised recommendations